KP Tissue Inc. shares fell by 3.01% in the last trading session, reflecting investor uncertainty.
KP Tissue Inc. (KPT.TO) saw its stock price drop by 3.01% during the last trading session, closing at CA$13.20. This decline comes amid mixed financial results and broader market volatility, leaving investors questioning the company's stability.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
KP Tissue Inc
KPT.TO
KPT.TO
KP Tissue Inc
WealthAwesomeMarket cap
$128.35M
P/E
14.2x
Div. yield
5.59%
Div. / share
$0.72
52W high
$13.61
52W low
$8.34
1W change
-2.74%
Beta
0.40
Analyst Price Targets
Based on analyst covering KPT
Wall Street analysts forecast KPT stock price to rise 0.6% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$12.88
+0.6% Upside
Current Price
C$12.80
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on KPT's historical volatility
30-Day Vol
17.1%
Annualized
90-Day Vol
16.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$15.30
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$13.59 | C$12.81 – C$14.41 |
| 60 trading days | C$14.42 | C$13.26 – C$15.67 |
| 90 trading days | C$15.30 | C$13.82 – C$16.95 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: The recent drop in KP Tissue's stock price highlights the importance of staying informed about market conditions and company performance, especially in a volatile economic environment.
KP Tissue Inc. Shares Drop 3.01%
The company's market cap now stands at CA$136.38 million, reflecting investor caution following the stock's recent performance.
Bull case
Despite the recent decline, KP Tissue has demonstrated strong profitability in its previous financial results, with a notable increase in adjusted EBITDA and net income. This suggests that the company has the potential to rebound and regain investor confidence.
Bear case
The stock's decline raises concerns about the company's ability to sustain its financial momentum, especially with no recent news to reassure investors. This uncertainty could make it challenging for KP Tissue to attract new investment and maintain its current valuation.
Market Performance Overview
KP Tissue Inc. shares fell by 3.01% in the last session, closing at CA$13.20. This decline is significant given the company's recent financial performance, which had previously shown signs of growth. Investors may be reacting to broader market trends or uncertainties regarding the company's future outlook.
Financial Context
With a market cap of CA$136.38 million and a P/E ratio of 15.11, KP Tissue's valuation reflects mixed sentiment among investors. The company's profit margin stands at 0%, indicating challenges in profitability that could contribute to the stock's recent weakness. For more insights, check out our detailed analysis on KP Tissue's financials.
Looking Ahead
As KP Tissue prepares for its upcoming Annual Meeting of Shareholders, scheduled for June 15, 2026, investor focus will be on how management addresses current challenges and outlines future strategies. The lack of recent news may leave investors feeling uncertain, making it crucial to monitor any developments closely. For updates, visit our KP Tissue stock page.
Advertisement
Wealth Awesome Newsroom
The Wealth Awesome Newsroom delivers timely Canadian market updates, earnings, dividends, and stock movers for DIY investors. Coverage is reviewed against public filings and market data feeds.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
